FDA warns Milo’s Poultry Farms after Salmonella Enteritidis matched outbreak strain in shell eggs and facility.
What happened
During a joint FDA and Wisconsin inspection from August 15 to September 10, 2024, environmental swabs from the poultry house and processing facility tested positive for Salmonella Enteritidis. Whole genome sequencing matched the isolates to the outbreak strain and clinical isolates, and a shell egg sample was also positive for the same strain. FDA also observed Shell Egg Rule violations and insanitary conditions in the processing environment.
What FDA found
The farm did not have and implement a written Salmonella Enteritidis prevention plan covering all required measures.
21 CFR 118.4The farm did not follow its written biosecurity measures, including visitor limits, equipment use, and rules on employees keeping birds at home.
21 CFR 118.4(b)The farm used bait stations without traps or documented thresholds and corrective actions, and did not document weekly visual inspections.
21 CFR 118.4(c)(1)The farm did not have an adequate fly monitoring method or objective threshold for unacceptable fly activity.
21 CFR 118.4(c)(2)Manure, uncut weeds, unused fencing, traps, and pallets were present near or in poultry house areas that can harbor pests.
21 CFR 118.4(c)(3)FDA observed residue buildup on food-contact and non-food-contact surfaces, no sanitizer use, and practices that could spread filth and pathogens.
FD&C Act section 402(a)(4)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of the steps taken to address the violations, with explanations and supporting documents. If corrective actions cannot be completed in that time, the company must state why and give a completion timeframe.
Who should pay attention
- shell egg farms and egg producers
- retailers and foodservice buyers of shell eggs
- contract processors or packers handling shell eggs
This is a summary. Read the original letter on fda.gov.